Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Neurology
•
Vascular Neurology
How do you manage acute ischemic stroke patients secondary to HUS/TTP?
Is there a certain platelet value cutoff that you would consider adding antithrombotics?
Related Questions
How long would you continue chronic transfusion therapy for adult sickle cell patients who have had a stroke?
What is your recommended long term management of extensive dural venous sinus thrombosis in an otherwise healthy young patient?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How to approach reversal of TNK in hemorrhagic conversion of ischemic stroke?
How do you manage high-risk MDS IB2 patients on HMA and venetoclax who develop an acute stroke requiring antiplatelet therapy?
What is the utility of a hypercoagulability workup in recurrent cryptogenic stroke, and what specific tests would you recommend?
How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?
How do you use cardiac biomarkers, if at all, in prognostication for patients with ischemic stroke?
Does TpA or TNK cause acute post infusion severe headache with no intracranial bleed?